about
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study.Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLAComplement alternative pathway activation in human nonalcoholic steatohepatitis.Protective role of plant sterol and stanol esters in liver inflammation: insights from mice and humansNeutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice.Genetic and epigenetic regulation of gene expression in fetal and adult human liversSmoothelin in vascular smooth muscle cells.Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis.Nicotine effect on inflammatory and growth factor responses in murine cutaneous wound healing.Wnt/frizzled signalling modulates the migration and differentiation of immortalized cardiac fibroblasts.Smoothelin-B deficiency results in reduced arterial contractility, hypertension, and cardiac hypertrophy in mice.Early insulin sensitivity after restrictive bariatric surgery, inconsistency between HOMA-IR and steady-state plasma glucose levels.Liver manipulation during liver surgery in humans is associated with hepatocellular damage and hepatic inflammation.Smoothelin expression during chicken embryogenesis: detection of an embryonic isoform.Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.Short-term overfeeding induces insulin resistance in weight-stable patients after bariatric surgery.Structure and chromosome location of Smtn, the mouse smoothelin gene.Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.Neutrophil activation in morbid obesity, chronic activation of acute inflammation.Smoothelin-a is essential for functional intestinal smooth muscle contractility in mice.Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals.Small intestinal alterations in severely obese hyperglycemic subjects.The Cholesterol Derivative 27-Hydroxycholesterol Reduces Steatohepatitis in MiceTotal Parenteral Nutrition Induces a Shift in the Firmicutes to Bacteroidetes Ratio in Association with Paneth Cell Activation in RatsCultured porcine coronary artery smooth muscle cells. A new model with advanced differentiationEndothelial activation markers and their key regulators after restrictive bariatric surgeryContribution of serum response factor and myocardin to transcriptional regulation of smoothelinsDecreased nucleotide excision repair in steatotic livers associates with myeloperoxidase-immunoreactivityNovel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitisActivation of the complement system in human nonalcoholic fatty liver diseaseEndogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosisNon-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breathSix months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetesNε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistanced-amino Acids in Health and Disease: A Focus on CancerThe endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver diseaseThe Clinical Link between Human Intestinal Microbiota and Systemic Cancer TherapyDiet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study
P50
Q31113843-DAAD3FE7-D0AB-4785-9A0E-28F5DAF57F47Q33650368-8DAA4D15-8E00-43DA-BF72-DC846812014BQ33987569-BCA739FA-F832-4B5D-ADDE-3D1CDB8AF1DFQ34317685-B518F4CC-BC5D-461B-8DDB-DC6588B78E0BQ34428267-006F8E62-653D-4996-96A9-3A4B7E82DBEEQ34533851-8ADDEA44-C732-4F6D-891D-AAF1AFCBA60EQ35302040-9CF8EFC4-ED38-4CC7-8D00-FEAB644130C3Q36702343-064F4E5A-4EB4-4DB0-88C6-B6383D748B05Q36870887-FB6D685A-9B3D-4E08-AFE6-A61F91AD4ADCQ37362066-236A74B8-AD6D-425A-9EE5-192955F887E0Q39066163-9A10F772-40C4-4E38-9094-7E1BB228452BQ39734163-45E774B4-5C5B-47EF-8126-EB07AE7D6EACQ41791626-3D860ED1-E92C-4FC4-A883-FD73B4BEA55FQ43185621-DD849112-A09E-4752-8BD8-26CD78326978Q43538921-35E14FE9-99CB-4053-BE79-A1301B3A0534Q43704517-FD7FE293-1FB7-47FC-A834-7D691A096C7FQ45092471-3C415A32-3BE4-4D38-AB61-98C2AD427BEAQ46806860-43C6718C-DC0A-47AD-A660-54B07A132018Q47833438-9BDC3162-8A9A-4970-AF30-03B0C45961BEQ47846619-FBBBD940-C40D-4D3D-9DCE-6800BC8A1BD5Q47951282-608F54EE-B9AC-4F29-B0DA-FEAC818D7350Q52567163-4133518F-CCDE-478D-8F1C-7ECE6C1D0447Q54368082-15E3F96C-FCB0-4658-B750-DEE9A275BDBAQ54401466-0D4D9544-E673-4B52-AF06-535D0D2B36E5Q56507986-C582B870-4D81-480F-B0E2-FFD5D6D4E167Q63379512-1BC7013D-2536-4751-AEE0-1C4FC30B8C30Q77986145-4F5EC26A-725E-4159-9805-C6DC23666729Q80451527-1FE06D9B-ABD1-4103-B518-8D7C879D33E8Q82443778-7B4DC670-6D85-471B-AB38-1354E502F8EBQ82595363-9F505A78-46DA-4DDF-9937-D36B876F04D2Q84596379-3165D71C-0700-4F23-88F7-6F187942DDF0Q84702184-4D72907B-A6E0-4722-BC6A-C286BD1AC52FQ84930023-622BC08A-5DBF-4505-A415-A2F5AAC1214BQ85407654-89A7D7BC-81BF-4AC5-BFE2-6A95088249B0Q86983843-2D6BAD8E-400A-4841-B741-7DD0AB74306AQ87661934-E7AFFDAD-D4ED-48CB-B1CF-085732E8F599Q90231367-C0025C15-0471-4AE9-8909-4C2636ADA195Q92791721-D019DA7B-481A-444C-A30D-0186F0FC8913Q92875095-7CEE0D19-C228-4EA8-882D-716D48DB75ABQ92894903-4F4A84C7-4B83-4A86-85AE-3BA583F309DE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sander Rensen
@ast
Sander Rensen
@en
Sander Rensen
@es
Sander Rensen
@nl
Sander Rensen
@sl
type
label
Sander Rensen
@ast
Sander Rensen
@en
Sander Rensen
@es
Sander Rensen
@nl
Sander Rensen
@sl
altLabel
S. Rensen
@nl
prefLabel
Sander Rensen
@ast
Sander Rensen
@en
Sander Rensen
@es
Sander Rensen
@nl
Sander Rensen
@sl
P106
P21
P31
P496
0000-0001-5054-8400
P735
P7449
PRS1312061